Benzenemethanethiol

Benzenemethanethiol

SCHEMBL2431700

F.SCc1ccccc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112289937-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-23 CN claimed
CN-110192294-A LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME 株式会社LG化学 2019-08-30 CN claimed
CN-104817801-B Inorganic-organic Hybrid Material and the optical material and inorganic-organic composite composition for having used the Inorganic-organic Hybrid Material 日本化成株式会社 2017-07-18 CN disclosed
US-8865428-B2 Protein production method, fusion protein, and antiserum NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2014-10-21 US disclosed
US-20110223686-A1 PROTEIN PRODUCTION METHOD, FUSION PROTEIN, AND ANTISERUM IDEMITSU KOSAN CO., LTD. (JP) 2011-09-15 US disclosed
US-7790849-B2 Method for gene transfer into target cells with retrovirus; improves retroviral vector mediated gene transfer efficiency into target cells TAKARA BIO INC. (JP) 2010-09-07 US disclosed
US-20090209730-A1 Method for gene transfer into target cells with retrovirus; improves retroviral vector mediated gene transfer efficiency into target cells ASADA KIYOZO 2009-08-20 US disclosed
US-7446170-B2 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector TAKARA BIO INC. (JP) 2008-11-04 US disclosed
EP-0870839-B1 METHOD FOR GENE INTRODUCTION INTO TARGET CELLS BY RETROVIRUS TAKARA BIO INC (JP) 2006-05-10 EP disclosed
US-20060030046-A1 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector TAKARA BIO INC., A CORPORATION OF JAPAN (JP) 2006-02-09 US disclosed
US-6949623-B2 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells TAKARA BIO INC. (JP) 2005-09-27 US disclosed
US-5883075-A HYPOTENSIVE AGENT CYCLIC PEPTIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
EP-0870839-A1 METHOD FOR GENE INTRODUCTION INTO TARGET CELLS BY RETROVIRUS TAKARA SHUZO CO. LTD. (JP) 1998-10-14 EP disclosed
EP-0528312-B1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-07-16 EP disclosed
US-5616684-A CYCLIC HEXAPEPTIDE CONTAINING ASPARTIC ACID AND DERIVATIVES, 2-THIENYLGLYCINE, LEUCINE, AND TRYPTOPHAN; ENDOTHELIN RECEPTOR ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-01 US disclosed
EP-0434836-B1 METHOD FOR PURIFYING TENASCIN RIKAGAKU KENKYUSHO (JP) 1995-10-25 EP disclosed
EP-0606881-A1 Cyclic pentapeptides having a beta-turn and a gamma-turn TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-20 EP disclosed
EP-0552417-A1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-07-28 EP disclosed
EP-0528312-A2 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-02-24 EP disclosed
EP-0434836-A1 METHOD FOR PURIFYING TENASCIN RIKAGAKU KENKYUSHO (JP) 1991-07-03 EP disclosed